Target intelligence / Profile preview

Gamma oscillations (Gamma) (Gamma)

Target
Gamma
Molecular classification
Other (Network-level physiological process)
01

Overview

Gamma oscillations are rhythmic patterns of neural activity occurring in the 30 to 100 Hz frequency range, representing the synchronized firing of local neuronal populations. These oscillations are primarily generated by the reciprocal interaction between excitatory pyramidal cells and inhibitory interneurons, particularly parvalbumin-positive (PV+) cells (Buzsáki & Wang, 2012, Annual Review of Neuroscience). They are essential for high-level cognitive processes such as attention, working memory, and sensory integration by facilitating temporal coordination between brain regions (Uhlhaas & Singer, 2010, Nature Reviews Neuroscience). In various neurological and psychiatric disorders, including Alzheimer's disease and schizophrenia, gamma oscillations are frequently disrupted or diminished, contributing to cognitive impairment (Adaikkan & Tsai, 2020, Neurotherapeutics). While not a single molecular entity, gamma oscillations serve as a functional target for therapeutic intervention through pharmacological agents like GABAergic modulators or non-invasive techniques like sensory entrainment and transcranial stimulation (Iaccarino et al., 2016, Nature). Modulating these rhythms aims to restore network-level communication and improve clinical outcomes in patients with neurodevelopmental or neurodegenerative conditions.

Other names
Gamma wavesNeural synchronyGamma-band activityHigh-frequency oscillationsNeural network synchronization
02

Mechanism of action

Modulation of GABAergic interneuron activity (specifically parvalbumin-positive cells), NMDA receptor signaling, and cholinergic enhancement to restore or stabilize rhythmic neural firing patterns.

03

Biological functions

Cognitive processingMemory consolidationAttentionSensory perceptionNeural communication
04

Disease associations

Alzheimer's diseaseSchizophreniaAutism spectrum disorderEpilepsyMajor depressive disorder
05

Safety considerations

Risk of seizure induction (pro-convulsant effects)Dissociative side effectsPotential for cognitive disruption if over-synchronizedTherapeutic challenge of non-invasive entrainment durability
06

Interacting drugs

Ketamine

5 more in the full profile.

07

Biomarkers

EEG gamma powerMEG phase-locking valueGamma-band auditory steady-state response (ASSR)Phase-amplitude coupling

Beyond the preview

Go deeper on Gamma oscillations (Gamma) (Gamma).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Gamma oscillations (Gamma) (Gamma).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call